Biotika a.s. (BSSE:1BSL01AE)

Slovakia · Delayed Price · Currency is EUR

10.80

0.00 (0.00%)

At close: Jun 12, 2026

-16.92% (1Y)

Market Cap	7.56M -80.3%
Revenue (ttm)	18.15M +5.3%
Net Income	-1.19M
EPS	-1.70
Shares Out	700.00K
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10
Open	10.80
Previous Close	n/a
Day's Range	10.80 - 10.80
52-Week Range	7.00 - 12.00
Beta	0.12
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 26, 2026

About Biotika a.s.

Biotika a.s., a biotechnology company, operates as a pharmaceutical manufacturing company in Slovakia and internationally. It offers active pharmaceutical ingredients (API), including Phenoxymethylpenicillin Potassium and Polymyxin B Sulfate. The company is also involved in the contract manufacture of APIs comprising Gramicidin S Hydrochlorid. In addition, it produces and sells cosmetic products; beverages, protein substances, and its derivatives; disinfectants and organic chemical; compost and organic fertilizer; medical devices; veterinary me... [Read more]

Industry Pharmaceutical Preparations

Founded 1953

Employees 165

Stock Exchange Bratislava Stock Exchange

Ticker Symbol 1BSL01AE

Full Company Profile

Financial Performance

In 2025, Biotika a.s.'s revenue was 18.15 million, an increase of 5.30% compared to the previous year's 17.24 million. Losses were -1.19 million, -50.25% less than in 2024.

Financial Statements